Latest news articles

Added 1 month ago Drug news

Results from UNTOUCHED study of EMBLEM defibrillator for prevention of sudden cardiac death

Boston Scientific announced acute results from the UNTOUCHED study evaluating safety and efficacy of the EMBLEM Subcutaneous Implantable Defibrillator (S-ICD)...

Added 1 month ago Drug news

FDA approves Praluent for heart attack and stroke prevention

The FDA has approved Praluent (alirocumab), from Regeneron, to reduce the risk of heart attack, stroke, and unstable angina requiring...

Added 2 months ago Drug news

Analysis of phase III DECLARE-TIMI 58 trial showed that Farxiga reduced the risk of adverse CV events

Positive results from a pre-specified sub-analysis of the Phase III DECLARE-TIMI 58 trial showed that Farxiga (dapagliflozin) from AstraZeneca, reduced...

Search all news articles for Cardiac arrest and ventricular fibrillation
 

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

ESICM LIVES Highlights

ESICM LIVES Highlights

ESICM LIVES Congress 2018: Bringing you the latest news and insights from the 31st ESICM LIVES Congress, 20–24 October 2018 Paris, France.

Fibrinogen Deficiency in Bleeding

Fibrinogen Deficiency in Bleeding

Fibrinogen is important for blood clot formation and breakdown. It is the first coagulant factor to be reduced to critical levels during massive trauma, cardiac surgery and postpartum haemorrhage that involve excessive bleeding. Persistent fibrinogen deficiency can lead to bleeding complications and an increased risk in mortality. This learning zone looks at both congenital and acquired fibrinogen deficiencies including indications and techniques for diagnosis, trigger level for treatment and treatment options.

Load more

Guidelines

2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

In light of the very recent consensus documents for the management of patients with VA released by the major international heart rhythm societies, the ESC Guidelines Committee decided to focus the content of this document on the prevention of SCD.

Added 3 years ago

Search all guidelines for Cardiac arrest and ventricular fibrillation
 

Journal articles

Effect of 0.9% Saline or Plasma-Lyte 148 as Crystalloid Fluid Therapy in the Intensive Care Unit on Blood Product Use and Postoperative Bleeding After Cardiac Surgery

To evaluate the effect of Plasma-Lyte 148 (PL-148) compared with 0.9% saline (saline) on blood product use and postoperative bleeding in patients admitted to the intensive care unit (ICU) following cardiac surgery.

Added 11 months ago

Perioperative Use of Levosimendan Improves Clinical Outcomes in Patients Post-Cardiac Surgery: A Systematic Review and Meta-analysis.

Severe postoperative complications can affect cardiac surgery patients. Levosimendan is a novel calcium sensitizer commonly administered after cardiac surgery.

Added 1 year ago

Prasugrel hydrochloride for the treatment of acute coronary syndromes.

Introduction: P2Y12 receptor antagonists, by inhibiting platelet activation and subsequent aggregation, are critical to prevent ischemic event recurrence after an...

Added 4 years ago

Search all journal articles for Cardiac arrest and ventricular fibrillation
 

CME

Basic life support

Accrediting body
Union of European Medical Specialists (via European Accreditation Council for CME)
Credits available
1
Registration required
1
Subscription fee
90
Search all CME for Cardiac arrest and ventricular fibrillation